Composition containing novel compound for preventing or treating parkinson's disease
WO2025023339A1PCT designated stage expired Publication Date: 2025-01-30PRG S&TECH INC
Patent Information
- Application Number
- PCT/KR2023/010642
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2023-07-24
- Publication Date
- 2025-01-30
Smart Images
Figure KR2023010642_30012025_PF_FP_ABST
Abstract
The present invention relates to a use of a novel compound for preventing, alleviating, or treating Parkinson's disease, the novel compound exhibiting an effect of inhibiting synuclein aggregation in a Parkinson's disease (PD) mouse model. As a result of histological analysis, it was confirmed that the loss of dopaminergic neurons was blocked by treatment with the novel compound. Therefore, the novel compound can be effectively utilized in the development of a therapeutic agent for Parkinson's disease.
Need to check novelty before this filing date? Find Prior Art
Citation Information
Patent Citations
Novel decursin derivative, the preparation thereof and a composition containing the same for treating and preventing cancer disease
KR1020080004332A
Medical snare apparatus capable of injecting solution into polyp's submucosa and electrocauterization in one step
KR1020220145579A
Automated sputtering apparatus of metal thin film for manufacturing sample of scanning electron microscope
KR1020230151565A
A composition comprising decursin derivative for preventing or treating of tuberculosis
KR102042411B1
KR20240006143A